Oncopeptides
Oncopeptides is developing several new compounds based on its proprietary technology platforms and is listed on Nasdaq Stockholm with the ticker ONCO. For more information see: www.oncopeptides.com
Oncopeptides Srl
Via Ceresio 7 – 20153 Milano
www.oncopeptides.it
AbbVie
Daiichi Sankyo
Daiichi Sankyo Europe GmbH
Zielstattstr. 48
81379 Munich
Tel: +49 89 78080
www.daiichi-sankyo.eu
[email protected]
Menarini Ricerche
Menarini Ricerche is a Research and Development hub of the Menarini Group.Together with Stemline Therapeutics, Menarini R&D is committed to innovation and patient care, focusing on the development of new personalised cancer drugs, as well as in new life science technologies aimed at non-invasive diagnosis to identify the best treatment option for each individual patient. Menarini develops projects from the preclinical phase to drug registration, including both small molecules and biologics, with a primary focus in Oncology. With research centers across Europe, the US, and Southeast Asia, Menarini invests heavily in research, personalized cancer treatments and advanced diagnostics.
Menarini Ricerche S.p.A.
Via Sette Santi
3 Firenze – Italy
Tel: +39 055 5680
www.menarini.com/en-us/innovation-research
[email protected]
Otsuka Pharmaceutical Italy Srl
Via Fabio Filzi 29
20124 Milano
Tel: +39 (0)2 00632 710
www.otsuka.it
BeiGene
BeiGene, which plans to change its name to BeOne Medicines Ltd., is a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of nearly 11,000 colleagues spans five continents. To learn more about BeiGene, please visit www.beigene.com and follow us on LinkedIn, X (formerly known as Twitter), Facebook and Instagram.
BeiGene Italy Srl
Piazzale Biancamano 8
20121, Milano
www.beigene.com
Bristol Meyers Squibb
Bristol Meyers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and make available innovative medicines dedicated to patients fighting serious diseases. We are inspired by a single vision: transforming patients’ lives through science. Patients are, in fact, at the center of everything we do; it is for them that we strive for scientific excellence, investing in research and development to make available innovative, high-quality medicines that meet unmet clinical needs.
Bristol Myers Squibb
Piazzale dell’Industri
40-46, 00144 Roma
Tel: +39 (0)6 503961
